A randomized, double-masked, placebo-controlled parallel study of 0.2% loteprednol etabonate in patients with seasonal allergic conjunctivitis

199876 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Allergy and Clinical Immunology

Volume 102, Issue 2, pp. 251-255

Field-Weighted Citation Impact: 5.25